3419 results for «2024»
3419 results
EuroIntervention: your academic reference journal for coronary, valvular and structural interventions
07 Feb 2024
EuroIntervention Journal is an international, English language, peer-reviewed journal which publishes high quality academic research in coronary, valvular, structural and surgical cardiovascular interventions.
It’s been an inspiring, record-breaking year for PCR Courses!
18 May 2023
In-person events are back on the agenda, and the past year has seen the happy return of onsite editions for all PCR Courses. Key figures show that the community continues to prefer the unequalled educational value of face-to-face exchange. Simultaneously, those who are not in a...
Digital coverage of PCR London Valves 2025
Mitral session from PCR London Valves 2025: Abbott
26 Nov 2025
Watch these recordings from PCR London Valves 2025 and EuroPCR 2025 on Mitral.
TAVI session from PCR London Valves 2025 : Abbott
26 Nov 2025
Watch these recordings from PCR London Valves 2025 on TAVI.
Editorial: Hypertension and Renal Denervation
20 Sep 2024
Hypertension is the number one cause of years of life lost, and, perhaps more importantly, years of healthy living lost. It causes at least half of all heart attacks and strokes and is the major driver of heart failure.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
Celebrating 20 years of EuroIntervention!
22 May 2025
According to Editor-in-Chief, Davide Capodanno, EuroIntervention marks this milestone by continuing its upward trajectory, blending cutting-edge and traditional elements to bring the latest data to its readers faster than ever before.
Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months
28 Oct 2024
Pi-Cardia reports first commercial cases with ShortCut™
03 Mar 2025
Feasibility of sheathless Impella for protected percutaneous coronary intervention: a single-center experience
02 May 2025
Impella CP microaxial flow pump supports complete revascularisation during high-risk PCI, but standard implantation often leads to vascular complications. This article explores an initial experience with a sheathless implantation technique, which shows promise as a feasible and safe alternative.
First-in-human data for Sensome clot-sensing guidewire used in ischemic stroke treatment demonstrate ability to automate clot characterization with no safety issues
05 Jun 2024
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
Tricuspid Valve sessions from PCR London Valves 2025: Abbott
26 Nov 2025
Watch these recordings from PCR London Valves 2025 and EuroPCR 2025 on tricuspid valve.
GENESIS-II study reveals promising 30-day results for the hydra self-expanding transcatheter aortic valve
16 May 2024
SMT Announces Completion of Patient Enrolment for TUXEDO-2 Trial
16 Aug 2024
Pi-Cardia’s ShortCut™ Becomes First Leaflet Modification Technology to Receive CMS NTAP for Valve-in-Valve TAVR
06 Aug 2025
Gore Cardioform ASD occluder implantation for late progression of TR after Triclip
12 Mar 2025
Late progression of TR following T-TEER is not uncommon and may be challenging to treat due to anatomical and technical limitations. This is the 1st report of Gore Cardioform ASD Occluder implantation to treat recurrent severe TR after T-TEER.
A short history of the Euro4C Group
16 Jan 2019
Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.
